Indolizine derivatives and their use as antidiabetics

Details for Australian Patent Application No. 2007331871 (hide)

Owner Merck Patent GmbH

Inventors Burgdorf, Lars Thore; Tsaklakidis, Christos; Mederski, Werner; Beier, Norbert; Klein, Markus; Gericke, Rolf

Agent Davies Collison Cave

Pub. Number AU-B-2007331871

PCT Pub. Number WO2008/071288

Priority 10 2006 058 236.5 11.12.06 DE

Filing date 17 November 2007

Wipo publication date 19 June 2008

Acceptance publication date 23 August 2012

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437

Event Publications

30 July 2009 PCT application entered the National Phase

  PCT publication WO2008/071288 Priority application(s): WO2008/071288

23 August 2012 Application Accepted

  Published as AU-B-2007331871

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007331874-Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin

2007331865-Tamping machine for packing ballast under a track